Fetal calf sera can distort cell-based luminescent proteasome assays through heat-resistant chymotrypsin-like activity

Abstract

Luminescence-based proteasome activity assays use specific substrates that are supposed to be cleaved by cellular proteasome activity leading to luciferase substrates. Usually, control wells containing cell culture medium supplemented with antibiotics and fetal calf serum are used as background. Using the Proteasome-Glo chymotrypsin-like cell-based assay from Promega, we show here that fetal calf sera from different manufacturers contain heat-resistant, bortezomib-inhibitable, chymotrypsin-like activities that can interfere with proteasome activity assays. These data strongly recommend the use of pure phosphate-buffered saline (PBS) or serum-free medium during proteasome activity assays to diminish background luminescence and, thus, to obtain reliable results.

Keywords: Bortezomib; Carfilzomib; Fetal calf serum; Heat resistance; Proteasome activity; Proteasome-Glo chymotrypsin-like cell-based assays.